Research Article
Yunvjian-Medicated Serum Protects INS-1 Cells against Glucolipotoxicity-Induced Apoptosis through Autophagic Flux Modulation
Figure 3
Molecular function statistical distribution chart of differentially expressed proteins under each GO category (2nd Level). (a) 54.2% protein related to binding and 28.0% to catalytic activity in the HG/HL group compared with the control group. (b) 53.8% protein related to binding and 26.9% to catalytic activity in the HG/HL+10% YNJ-medicated serum group compared with the control group. (c) 52.5% protein related to binding and 27.7% to catalytic activity in the HG/HL +10% YNJ-medicated serum group compared with the HG/HL group.
| (a) |
| (b) |
| (c) |